Visit us at booth 1418 and find out how our genetic analysis solutions can advance your clinical research

As we move closer to realizing the practice of precision medicine, we are committed to developing genetic analysis tools that enable simple and rapid molecular analysis of samples across cancer, infectious disease, and inherited disease research.

We look forward to meeting you at the Association for Molecular Pathology (AMP) 2016 Annual Meeting to discuss new and established solutions for clinical research.

Nov 09, 2016 - Nov 12, 2016
Booth #1418

Download our handy show guide to plan your visits to our booth and poster sessions.

Get show guide ›

Corporate Workshop Day | November 9, 2016 | Charlotte Convention Center, Ballroom B

Workshop 1: Oncology clinical research—precision genomics is now routine

Time: 10:00–10:50 am

The most established platform used in tumor assays analysis highlights studies of how low you can go with formalin-fixed, paraffin-embedded (FFPE) solid tumor samples and fine-needle aspirates.  In addition, hear how an assay developer establishes Sanger sequencing assays for clinical research laboratories.

  • Title: Next-generation sequencing identifies mutational distinction between primary and metastatic adenocarcinoma in lung and colorectal cancer: potential therapeutic implications
    Speaker: Jean Lopategui, MD, Associate Professor of Pathology and Medical Director, Molecular Pathology and Clinical Cytogenetics, Cedars-Sinai Medical Center
  • Title: An update on the development of FLT3 and B and T cell clonality capillary electrophoresis kits for FDA submissions
    Speaker: Jordan Thornes, Director of Manufacturing Technical Support, Invivoscribe
Workshop 2: Pharmacogenomic studies and a new paradigm for infectious disease detection in women’s health

Time: 11:00–11:50 am

The use of high-throughput genomic technologies such as real-time PCR has rapidly increased our knowledge in the identification of single and mixed infectious disease agents, which may improve the future of health care. Join this workshop to hear researchers from leading laboratories present results on how they are balancing the multiplexing of target gene detection and sample/project size to enable efficient identification of microbes and study CYP2D6 mutations in a rapid manner.

  • Title: Advancing pharmacogenetic testing through the combination of IDgenetix™ medication management algorithms and Thermo Fisher Scientific platforms
    Speaker: Andrew Lukowiak, MD, Senior Vice President of Operations and Head of Scientific Affairs, AltheaDx
  • Title: Development of a high-throughput, real-time PCR–based test for identifying bacterial vaginosis
    Speaker: Doug Rains, Chief Scientific Officer, Quantigen Genomic Services
Workshop 3: Cell-free DNA analysis and immune response research using next-generation sequencing

Time: 1:00–1:50 pm

Research on tumor-specific mutations from cell-free DNA has led to alternate approaches being considered for monitoring tumor response to therapy and resistance, selecting second- and third-line therapies, and detecting residual disease in the future. Next-generation sequencing (NGS) techniques now enable clinical researchers to detect relevant somatic alterations with variant allelic frequencies as low as 0.1% with confirmation using digital PCR. Join us in this workshop where researchers from leading clinical labs discuss NGS molecular profiling methods with Oncomine™ cfDNA assays using plasma from lung cancer research samples.

  • Title: Next-generation sequencing immune cancer profiling in a clinical research lab
    Speaker: Jeffrey M. Conroy, Co-Director of the Genomics Shared Resource, Roswell Park Cancer Institute, and Senior Vice President of Technology Development at OmniSeq Precision Medicine Technology
  • Title: Evaluation of cell-free DNA assays for peripheral monitoring in the future
    Speaker: Kelli Bramlett, Director, R&D Applications, Thermo Fisher Scientific*

Interested in attending Affymetrix (part of Thermo Fisher Scientific) workshops on the latest gene expression solutions for clinical research applications? Sign up here ›

*Speaker change


Booth highlights | November 10–12, 2016

Visit us at booth #1418 to talk to one of our specialists about:

New and featured products in the booth


Scientific posters and talks highlighting our latest developments in clinical research

Poster: A Next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1/2 Simultaneous to Small Mutation Detection from FFPE Samples
Qi, R., Scafe, C., Nistala, G., Bee, G., Garg, N., Manivannan, M., Broomer, A., Mittal, V., Williams, P., Brinza, D., Hyland, F., Bishop, J., Sadis, S., Passkiewicz, B., Sherlock, J., Thermo Fisher Scientific, 200 Oyster Point Blvd, South San Francisco, CA 94080, USA

Poster: High Sensitivity Sanger Sequencing for Minor Variant Detection
Leong, H., Schreiber, E., Berosik, S., Chen, S., George, W., Marks, J., Schneider, S., Thermo Fisher Scientific, 200 Oyster Point Blvd, South San Francisco, CA 94080, USA

Poster: Information Genetic Content: a comprehensive discovery platform for disease-gene research association
Zhu, Y., Williams, E., Tian, Y., Munroe, C., Bucci, J., Fu, Y., Hyland, F., Shtir, C., Thermo Fisher Scientific, 200 Oyster Point Blvd, South San Francisco, CA 94080, USA and Thermo Fisher Scientific, 5791 Van Allen Way, Carlsbad, CA 92008, USA

Poster: Speeding up sequencing: Sequencing in an hour enables sample to answer in a workday
Davidson, C., Landes, M., Qi, R., Parikh, C., Mandelman, D., Latif, H., Harris, A., Nasan, N., Ghosh, S., Thermo Fisher Scientific, 200 Oyster Point Blvd, South San Francisco, CA 94080, USA and Thermo Fisher Scientific, 5791 Van Allen Way, Carlsbad, CA 92008, USA and CosmosID, 155 Gibbs St #436, Rockville, MD 20850 USA

Poster and platform talk: Computational methods for detection of somatic mutations at 0.05% frequency from cfDNA
Brinza, D., Chen, R., Schageman, J., Ballesteros-Villagrana, E., Chaudhary, R., Gu, J., Bagai, V., Kshatriya, P., Li, Y., Dhingra, D., AuYoung, J., Hyland, F., Bramlett, K., Thermo Fisher Scientific, 200 Oyster Point Blvd, South San Francisco, CA 94080, USA

Poster: Ion Torrent™ Next Generation Sequencing -Oncomine™ cfDNA Lung assay detected 0.1% low frequency somatic variants in Cell-Free DNA
Li, Y., Lea, K., Kshatriya, P., Gu, J., Ballesteros-Villagrana, E., Schageman, J., Bagai, V., Brinza, D., Chien, R., Bramlett, K., Thermo Fisher Scientific, 200 Oyster Point Blvd, South San Francisco, CA 94080, USA

Poster: High-throughput processing to maximize genomic analysis through simultaneous recovery of DNA and RNA from the same FFPE sample in separate eluates
Cheng, A., Hernandez,N., Sunnadeniya, R., Meza, D., Whiting, J., Fang, X. Thermo Fisher Scientific, Carlsbad, CA

Poster: Comparison of type and time of fixation on DNA sequencing results from tissues
Brown, R., Elliott, K., Freeland, J., Donoghue, S., Biorac, T., Kong, B., Sidhu,H., Veitch, J., Filiz, F., Chi, D., VanLoy,C., Isaac, J. Thermo Fisher Scientific, Kalamazoo, MI; Carlsbad, CA; West Sacramento, CA; South San Francisco, CA